2024 ICD-10-CM Diagnosis Code A91

Dengue hemorrhagic fever

A91 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
The 2024 edition of ICD-10-CM A91 became effective on October 1, 2023.
This is the American ICD-10-CM version of A91 – other international versions of ICD-10 A91 may differ.

The following code(s) above A91 contain annotation back-references

that may be applicable to A91:

Clinical Information

A serious condition caused by dengue virus infection. Patients present with an acute febrile illness followed by restlessness, irritability, and bleeding. It may lead to hemorrhagic shock and death.
A virulent form of dengue characterized by thrombocytopenia and an increase in vascular permeability (grades i and ii) and distinguished by a positive pain test (e.g., tourniquet pain test). When accompanied by shock (grades iii and iv), it is called dengue shock syndrome.

ICD-10-CM A91 is grouped within Diagnostic Related Group(s) (MS-DRG v41.0):

Convert A91 to ICD-9-CMCode History

2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
2017 (effective 10/1/2016): No change
2018 (effective 10/1/2017): No change
2019 (effective 10/1/2018): No change
2020 (effective 10/1/2019): No change
2021 (effective 10/1/2020): No change
2022 (effective 10/1/2021): No change
2023 (effective 10/1/2022): No change
2024 (effective 10/1/2023): No change

Code annotations containing back-references to A91:

Diagnosis Index entries containing back-references to A91: